| Diagnostic value | RBD suggests possible alpha-synuclein pathology as opposed to pure tauopathy |
| Safety concerns | Dream-enacting behaviors can lead to patient injury or injury to bed partners |
| Prognostic value | RBD may be associated with more rapid disease progression |
| Treatment implications | Clonazepam and melatonin may be used cautiously |
| Motor symptoms | Rigidity, dystonia, and myoclonus can make comfortable positioning difficult |
| Pain | Nocturnal pain from dystonia or abnormal postures disrupts sleep |
| Neuropsychiatric symptoms | Depression, anxiety, and agitation affect sleep initiation |
| Cognitive symptoms | Nocturnal confusion and sundowning may occur |
| Medications | Dopaminergic medications can cause nocturnal dyskinesias or insomnia |
| Associated Genes | alpha_synuclein |
| KG Connections | 53 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
No AI portrait yet
No comments yet. Be the first to comment!